Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1163)	6/27/2005 1:50:26 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

CGTK Is aiming for the resistance at 2.75 It needs to close above that before it can test its June 20 H at 2.93 The downgap of March 30 above the $3 level seems that it will have to wait for a while to be closed.And of course the one above the $10.75 level last Dec. is a different subject.<g> It announced today that its NF-kappaB Decoy drug candidate was effective in reducing disease activity in Crohn's disease and ulcerative colitis. The data was presented today at the 12th International Congress of Mucosal Immunology in Boston, MA. bigcharts.marketwatch.com Bernard